Continuous manufacturing is used in the pharmaceutical business. Mental Reorientation

Abstract

The manufacture of pharmaceuticals is subject to strict guidelines known as good manufacturing practice. Though
continuous processing might often result in the production of purer goods and thus have financial benefits, batch processing
has traditionally dominated the industrial industry.
After the product and process have been licensed, the regulatory framework often stifles any efforts to make changes to the
method. Because of this, many experts in the field now believe that batch operations are the only viable option. However, the
regulatory authorities, especially the Food and Drug Administration in the United States, have realized that continuous
processing has the potential to enhance product quality and are urging the sector to rethink its ideas. This study investigates
how chemical engineers might take use of the newfound freedom afforded them by these revised regulations to reevaluate
their own perspectives and inspire a paradigm shift in the field as a whole.